AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
Fred Hutch Cancer Center at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Fred Hutch Cancer Center brings 3 presentations to AMP 2026 in Seattle, its home city. Its sessions centre on residual disease detection and biomarker testing across blood and solid tumors. They cover high-color single-molecule PCR for monitoring blood cancers, Hi-C based testing that reveals genomic structure in lymphoma, lung cancer and sarcoma, and biomarker selection in genitourinary cancers.
| Organization | AMP 2026 Attendance |
|---|---|
Fred Hutch Cancer Center Seattle, WA | |
Cancer research center and treatment provider in Seattle, allied with UW Medicine. | Workshop Wed, Nov 11 12:00pm–12:50pm A New Detection Paradigm for Heme Oncology: High-Color Single-Molecule PCR for Reproducible MRD and Monitoring Single-molecule PCR across millions of partitions to count BCR::ABL1, KMT2A and other blood cancer variants reproducibly. Workshop Wed, Nov 11 2:00pm–2:50pm Aventa Clinical Testing Powered by Arima Hi-C: Revealing Actionable Genomic Structure Across Lymphoma, Lung Cancer, and Sarcoma Hi-C sequencing of FFPE tissue to map fusions and rearrangements in lymphoma, lung cancer and sarcoma cases. Workshop Wed, Nov 11 8:00am–8:50am The Precision Pathway: How Pathologists Are Transforming Biomarker Discovery, Selection, and Clinical Impact Across GU Cancers Biomarker selection, specimen handling and reporting for genitourinary cancers, worked through interactive case discussions. |
Find decision makers at Fred Hutch Cancer Center
Tell us what you sell and we’ll find the people at Fred Hutch Cancer Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction